Medication info
Bazediplus Tablet

Bazediplus Tablet

Prescription medicationTabletOral
Ingredient · strength
Bazedoxifene Acetate›22.6mg / 1 tabletCholecalciferol Concentrate Powder›8mg / 1 tablet
Manufacturer / importer
Medica Korea Co., Ltd.
Appearance
Pink rectangular film-coated tablet
Packaging
30 tablets / PTYP [10 tablets / PTP x 3]
Approval status
Active

MFDS item code 201804132 · Approved 2018.10.18 · Insurance code 646005340

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women
Who takes it
Adults
Adult dose
Take 1 tablet once daily, with or without food. If the patient's dietary intake of calcium and vitamin D is insufficient, supplements should be taken. Patients with renal impairment: This drug has not been adequately evaluated in patients with severe renal impairment and should be administered with caution. Patients with hepatic impairment: Use of this drug is not recommended in patients with hepatic impairment because its safety and efficacy have not been established.

Ingredients

Manufacturer
Medica Korea Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women

  • Osteoporosis
  • spinal fractures
View approved original text

This drug is used for the treatment and prevention of osteoporosis in postmenopausal women. It is particularly effective in reducing the occurrence of spinal fractures, however, its effect on non-vertebral fractures has not yet been definitively proven. Therefore, it helps protect spinal health and reduce the risk associated with osteoporosis.

How to take

Adult dose

Take 1 tablet once daily, with or without food. If the patient's dietary intake of calcium and vitamin D is insufficient, supplements should be taken. Patients with renal impairment: This drug has not been adequately evaluated in patients with severe renal impairment and should be administered with caution. Patients with hepatic impairment: Use of this drug is not recommended in patients with hepatic impairment because its safety and efficacy have not been established.

Precautions

This drug may increase the risk of blood clots in the bloodstream. It is necessary to discontinue use of this drug, especially if in a state of immobility or recovering from surgery. This drug should only be used by postmenopausal women and should not be taken by premenopausal women, pregnant women, or breastfeeding women. Patients who have an allergy to this drug or a history of thrombosis should also refrain from taking it. If uterine bleeding occurs while taking this drug, medical attention must be sought, and it is not recommended for patients with breast cancer. Patients with kidney or liver issues, hypertriglyceridemia, or restricted mobility should use this drug cautiously and follow their doctor's instructions. This drug may cause drowsiness or visual disturbances, so caution is needed when driving or operating machinery. If any visual changes are noticed, consult a doctor immediately. If calcium intake is insufficient, it is advisable to take calcium supplements, and patients at high risk of vitamin D deficiency may require additional vitamin D supplementation. In case of overdose, there is no specific antidote, and treatment should be symptomatic as symptoms of hypercalcemia or kidney stones may occur, so caution is advised. Keep out of reach of children and store in its original container to prevent degradation of quality or misuse.

Side effects

Hypersensitivity, drowsiness, retinal vein thrombosis, facial flushing, deep vein thrombosis, superficial thrombophlebitis, pulmonary embolism, dry mouth, urticaria, rash, itching, muscle cramps, peripheral edema, increased triglycerides in the blood, elevated alanine aminotransferase, elevated aspartate aminotransferase, decreased vision, blurred vision, photophobia, visual field defect, visual impairment, dry eye syndrome, eyelid edema, eyelid twitching, eye pain, swelling of the eye, vomiting, gastritis, colon polyps, belching, allergic reaction, chest discomfort, leg pain, fever, generalized edema, edema, facial edema, changes in temperature sensation, malaise, asthenia, fatigue, insufficient effect, dermatitis, localized skin reaction, increased sweating, eczema, hair loss, back pain, joint pain, muscular weakness, headache, dizziness, pharyngitis, pyelonephritis, palpitations, retinal hemorrhage, sputum disease, cough, asthma, shortness of breath, laryngitis, pleural effusion, increased alkaline phosphatase, liver cyst, hepatocellular damage, bile duct stones, weight gain, hyperlipidemia, central obesity, dysuria, abnormal urination, renal cyst, urinary incontinence, vaginal bleeding, breast congestion, insomnia, leukocytosis, laceration, bruise, psychological symptoms, consciousness disturbance, headache, nausea, loss of appetite, weight loss, increased thirst, arrhythmia, increased urinary frequency, kidney stones, renal calcification, calcification in the peripheral tissues of the bones, myalgia, joint pain

Not everyone experiences these, and they can vary from person to person.

Storage

This drug must be stored in a tightly closed container to protect it from air and moisture. Additionally, it is best stored at room temperature between 1°C and 30°C. Storing it this way helps maintain the drug's effectiveness.

Appearance and packaging

Appearance

Pink rectangular film-coated tablet

Package unit

30 tablets / PTYP [10 tablets / PTP x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.